• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌前病变进展为口腔癌:基于台湾全民健康保险数据库的结果。

Progression of precancerous lesions to oral cancer: results based on the Taiwan National Health Insurance Database.

机构信息

Graduate Institute of Statistics and Information Science, National Changhua University of Education, Changhua 500, Taiwan.

出版信息

Oral Oncol. 2013 May;49(5):427-30. doi: 10.1016/j.oraloncology.2012.12.004. Epub 2012 Dec 27.

DOI:10.1016/j.oraloncology.2012.12.004
PMID:23273345
Abstract

BACKGROUND

Oral cancer (OC) is the leading cause of death from cancer in men between the ages of 25 and 44 in Taiwan. The survival rate for the last stage of OC is <20% while that for the earliest stage is >75%, which suggests the importance of the diagnosis of oral precancerous lesions (OPLs) in reducing OC mortality. The aim of this study was to analyze the time to OC event after OPL diagnosis, and to suggest the surveillance period necessary according to OPL type.

MATERIALS AND METHODS

This was a retrospective cohort study based on 1.0 million people randomly selected from the Taiwan National Health Insurance Database, which provided data on 3058 adult male patients aged ≥20 years who were diagnosed with OPL for the first time between 1996 and 2009. The patient population was divided into two groups according to the type of lesion: oral submucous fibrosis (OSF) or oral leukoplakia (OLE). Age-standardized incidence rate (ASIR) and hazards rate (HR) were then estimated.

RESULTS

The ASIR for OPL showed an increasing trend over the study period, the main contributor to this being OSF. The OSF group demonstrated a higher OC incidence rate than the OLE group.

CONCLUSION

Patients with both OLE and OSF carry a higher risk for OC than those with either OLE or OSF alone, and they may also experience malignant transformation at an earlier date (mostly within 5 years). The 5- and 10-year OC rate for both OLE and OSF was found to be 5% and around 10%, respectively. However, 10 years after the diagnosis of OPL, OSF carries a higher risk of developing into OC than OLE.

摘要

背景

口腔癌(OC)是台湾 25 至 44 岁男性癌症死亡的主要原因。OC 晚期的存活率<20%,而早期的存活率>75%,这表明诊断口腔癌前病变(OPL)对于降低 OC 死亡率非常重要。本研究旨在分析 OPL 诊断后发生 OC 的时间,并根据 OPL 类型建议必要的监测期。

材料和方法

这是一项基于台湾全民健康保险数据库的回顾性队列研究,该数据库提供了 1996 年至 2009 年间首次被诊断为 OPL 的 3058 名 20 岁以上成年男性患者的数据。根据病变类型将患者分为两组:口腔黏膜下纤维化(OSF)或口腔白斑(OLE)。然后估计年龄标准化发病率(ASIR)和危害比(HR)。

结果

OPL 的 ASIR 呈上升趋势,主要原因是 OSF。OSF 组的 OC 发病率高于 OLE 组。

结论

患有 OLE 和 OSF 的患者比患有 OLE 或 OSF 单一病变的患者患 OC 的风险更高,而且他们也可能更早发生恶性转化(主要在 5 年内)。OLE 和 OSF 的 5 年和 10 年 OC 发生率分别约为 5%和 10%左右。然而,在 OPL 诊断 10 年后,OSF 发生 OC 的风险高于 OLE。

相似文献

1
Progression of precancerous lesions to oral cancer: results based on the Taiwan National Health Insurance Database.癌前病变进展为口腔癌:基于台湾全民健康保险数据库的结果。
Oral Oncol. 2013 May;49(5):427-30. doi: 10.1016/j.oraloncology.2012.12.004. Epub 2012 Dec 27.
2
Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.1458例潜在恶性口腔黏膜疾病患者的恶性转化:一项基于台湾某医院的随访研究。
J Oral Pathol Med. 2007 Jan;36(1):25-9. doi: 10.1111/j.1600-0714.2006.00491.x.
3
Environmental heavy metal as a potential risk factor for the progression of oral potentially malignant disorders in central Taiwan.环境重金属作为台湾中部口腔潜在恶性疾病进展的潜在风险因素。
Cancer Epidemiol. 2017 Apr;47:118-124. doi: 10.1016/j.canep.2017.02.003. Epub 2017 Mar 2.
4
Malignant transformation of oral submucous fibrosis in Taiwan: A nationwide population-based retrospective cohort study.台湾口腔黏膜下纤维性变的恶性转化:一项全国性基于人群的回顾性队列研究。
J Oral Pathol Med. 2017 Nov;46(10):1040-1045. doi: 10.1111/jop.12570. Epub 2017 Apr 6.
5
Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.p53和p63在口腔鳞状细胞癌、口腔白斑及口腔黏膜下纤维化中的免疫组化检测
J Investig Clin Dent. 2014 Aug;5(3):214-9. doi: 10.1111/jicd.12038. Epub 2013 Jun 18.
6
Multiple logistic regression analysis of risk factors for carcinogenesis of oral submucous fibrosis in mainland China.中国大陆口腔黏膜下纤维化癌变危险因素的多因素logistic回归分析
Int J Oral Maxillofac Surg. 2008 Dec;37(12):1094-8. doi: 10.1016/j.ijom.2008.06.010. Epub 2008 Aug 5.
7
Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis.胶原相关基因与槟榔诱导的口腔黏膜下纤维化易感性的相互作用
Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):646-53.
8
Profiling of chromosomal changes in potentially malignant and malignant oral mucosal lesions from South and South-East Asia using array-comparative genomic hybridization.使用阵列比较基因组杂交技术分析南亚和东南亚潜在恶性及恶性口腔黏膜病变中的染色体变化。
Cancer Genomics Proteomics. 2014 May-Jun;11(3):127-40.
9
Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program.口腔潜在恶性疾病亚类向口腔癌的恶性转化:台湾全国口腔癌筛查计划的前瞻性队列研究。
Oral Oncol. 2018 Dec;87:58-63. doi: 10.1016/j.oraloncology.2018.10.021. Epub 2018 Oct 24.
10
Cytokeratin expression in oral submucous fibrosis--an immunohistochemical study.口腔黏膜下纤维化中细胞角蛋白的表达——一项免疫组织化学研究
J Oral Pathol Med. 2006 Jan;35(1):25-32. doi: 10.1111/j.1600-0714.2005.00366.x.

引用本文的文献

1
Impact of oral precancerous lesions on oral cancer development in patients with oral lichen planus: a retrospective cohort study of 318 oral lichen planus patients.口腔癌前病变对扁平苔藓患者口腔癌发生的影响:一项对318例扁平苔藓患者的回顾性队列研究。
Front Oral Health. 2025 Mar 6;6:1560600. doi: 10.3389/froh.2025.1560600. eCollection 2025.
2
DNA Image Cytometry for Screening the Carcinogenetic Risk of Oral Potential Malignant Disorders.用于筛查口腔潜在恶性疾病致癌风险的DNA图像细胞术
J Cancer. 2024 Jan 1;15(5):1182-1190. doi: 10.7150/jca.91048. eCollection 2024.
3
Clinical evaluation of photodynamic therapy for oral leukoplakia: a retrospective study of 50 patients.
临床评价光动力疗法治疗口腔白斑病:50 例回顾性研究。
BMC Oral Health. 2024 Jan 3;24(1):9. doi: 10.1186/s12903-023-03791-5.
4
Mechanisms and markers of malignant transformation of oral submucous fibrosis.口腔黏膜下纤维化恶性转化的机制与标志物
Heliyon. 2023 Dec 7;10(1):e23314. doi: 10.1016/j.heliyon.2023.e23314. eCollection 2024 Jan 15.
5
INPP5A/HLA-G1/IL-10/MMP-21 Axis in Progression of Esophageal Squamous Cell Carcinoma.INPP5A/HLA-G1/IL-10/MMP-21 轴在食管鳞癌进展中的作用。
Iran Biomed J. 2022 Nov 1;26(6):440-53. doi: 10.52547/ibj.3716.
6
Systemic Investigation Identifying Salivary miR-196b as a Promising Biomarker for Early Detection of Head-Neck Cancer and Oral Precancer Lesions.系统性研究确定唾液miR-196b作为头颈癌和口腔癌前病变早期检测的有前景的生物标志物。
Diagnostics (Basel). 2021 Aug 4;11(8):1411. doi: 10.3390/diagnostics11081411.
7
Small Molecule "Silmitasertib" Repurposed as Inhibitor of Transforming Growth Factor Beta 1 for the Development of Therapeutics for Oral Submucous Fibrosis.小分子“西咪替塞替布”经重新利用,作为转化生长因子β1的抑制剂用于口腔黏膜下纤维化治疗药物的开发。
Biomed Res Int. 2021 Apr 1;2021:6631848. doi: 10.1155/2021/6631848. eCollection 2021.
8
Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.口腔黏膜下纤维性变:生物标志物、发病机制和治疗的综述。
Int J Mol Sci. 2020 Sep 30;21(19):7231. doi: 10.3390/ijms21197231.
9
TRG-AS1 is a potent driver of oncogenicity of tongue squamous cell carcinoma through microRNA-543/Yes-associated protein 1 axis regulation.TRG-AS1 通过 microRNA-543/Yes 相关蛋白 1 轴调控促进舌鳞状细胞癌的致癌性。
Cell Cycle. 2020 Aug;19(15):1969-1982. doi: 10.1080/15384101.2020.1786622. Epub 2020 Jul 2.
10
Expression of transforming growth factor beta in oral submucous fibrosis.转化生长因子β在口腔黏膜下纤维化中的表达
J Oral Biol Craniofac Res. 2020 Apr-Jun;10(2):166-170. doi: 10.1016/j.jobcr.2020.03.015. Epub 2020 Apr 13.